in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Fujifilm Diosynth opens cGMP facility in the UK, plans expansion
October 6, 2013 | Natasha Alperowicz
Fujifilm Diosynth Biotechnologies has opened a new cGMP mammalian cell culture manufacturing facility at Billingham, United Kingdom. The new facility is the first of its kind in the UK. It is purpose-built to utilize primarily single-use technologies for both upstream and downstream operations. Designed with input from regulatory authorities and key customers, it will offer high flexibility for meeting customers’ needs. It has initially been commissioned with 200 liter and 1,000 liter bioreactors, with a 2,000 liter bioreactor already planned for...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee